The antibiotic O-carbamyl-D-serine, an analogue of D-alanine, is an inhibitor of bacterial cell-wall biosynthesis (30) . It was demonstrated that the antibacterial activity could be reversed by D-alanine, and that an intracellular accumulation of N-acylamino sugar resulted when Bacillus subtilis was grown in the presence of the antibiotic. In (1) . Peptidoglycan synthetase catalyzes the polymerization of the acceptor (lipid)-phosphodisaccharide, with the formation of. peptidoglycan which is not cross-linked (1, 3) .
When bacteria are grown in the presence of LYNCH AND NEUHAUS accumulates is UDP-NAc-muramyl-L-ala-D-glu-L-lys-D-ala-D-ala (15, 16, 17, 19, 24) . In contrast, if S. aureus is grown in the presence of D-cycloserine, the major nucleotide that accumulates is UDP-NAc-muramyl-L-ala-D-glu-L-lys (28) . Strominger et al. (26) observed that D-cycloserine inhibits the D-ala-D-ala synthetase and the alanine racemase. Inhibitor studies (13) indicated that both D-alanine binding sites of the synthetase are sensitive to D-cycloserine. It was suggested that one of the primary sites of antibiotic action may be the donor site of the synthetase.
It is the purpose of this communication to define the mode of action of O-carbamyl-D-serine in the sequence of enzymes responsible for the introduction of alanine into the peptidoglycan portion of the wall. The major nucleotide which accumulates in the presence of O-carbamyl-Dserine is identified as UDP-NAc-muramyl-Lala-D-glu-L-lys. Of the four potential sites of action, which were examined, it was concluded that a primary site of action is the alanine racemase.
MATERIALS AND UDP-NAc-muramyl-L-ala-D-glu-L-lys and UDPNAc-muramyl-L-ala-D-glu-L-lys-D-ala-D-ala were prepared as previously described (14) . D-Ala[C'4]-Dala[C '4] was prepared with D-ala-D-ala synthetase (12) .
Growth of bacteria. Streptococcus faecalis R (ATCC 8043) was grown in the following medium: peptone-T, 1%; yeast extract, 1%; K2HPO4, 0.5%; glucose, 0.5%. Growth was arrested in the log phase by cooling, and the cells were harvested by centrifugation. A portion of a suspension in 0.01 M tris(hydroxymethyl)aminomethane (Tris)-HCI (pH 7.8) was used to inoculate tubes (10 ml) of medium containing inhibitor to an initial optical density of 0.1. The tubes were maintained at 37 C, and the turbidity was measured at 670 m,.
Enzyme preparations. Except for the phosphoNAc-muramyl-pentapeptide translocase, all extracts were prepared from S. faecalis R (ATCC 8043) according to procedures previously described (12) . A unit of enzyme is that amount which will catalyze the formation of 1 jAmole of product per min at 37 C. A sonic extract was used as a source of the alanine racemase (0.056 units per mg, "L-alanine to D-alanine assay"). D-Ala-D-ala synthetase (1.3 units per mg) was purified through the acetone fractionation (12) . For the "nucleotide-tripeptide assay" a 55 to 70% ammonium sulfate fraction (0.12 units per mg) was used (14) as a source of the D-ala-D-ala adding enzyme. For the experiments described in Fig. 9 , a diethylaminoethyl (DEAE)-Sephadex fraction (0.49 units per mg) was employed (14) . Phospho-NAc-muramylpentapeptide translocase (UMP) was prepared from S. aureus Copenhagen (Struve et al., in press).
Alanine racemase assay. The alanine racemase was assayed in both directions by converting the product to pyruvic acid. In the forward direction ("L-alanine to D-alanine assay"), D-alanine was deaminated with D-amino acid oxidase, and in the reverse direction ("D-alanine to L-alanine assay"), the L-alanine was deaminated with the glutamic-pyruvic acid transaminase. The C14-pyruvic acid was separated from the substrate by ion-exchange chromatography. For the deamination of L-alanine in the reverse reaction ("D-alanine to L-alanine assay"), 0.02 ml of a solution containing 36 jAmoles of a-ketoglutarate adjusted to pH 8.0 with NaOH and 4 jug of glutamicpyruvic acid transaminase was added to the reaction mixture (0.1 ml, first stage) and incubated at 37 C for 45 min. The reaction was terminated by the addition of 0.1 ml of 1 N HCl and 0.4 ml of 0.2 N sodium citrate (pH 2.2).
The labeled pyruvic acid in both assays was separated from C'4-alanine on a Dowex 50(Na+)X-8 (200 to 400 mesh) column (5 by 20 mm). The reaction mixture from the second stage was quantitatively applied to the column and eluted with two portions (0.7 ml each) of 0.2 N sodium citrate (pH 2.2). The eluate (2.0 ml) was collected in a polyethylene vial for the determination of radioactivity. Under these conditions, C'4-alanine was eluted between 6 and 10 ml. Appropriate controls were performed in each series to correct for the slow decomposition of the C'4-alanine to compounds not retained by the column. The amount of D-amino acid oxidase and glutamic-pyruvic acid transaminase was sufficient to deaminate 100 nmoles of D-or L-alanine. The usual amount of D-or L-alanine converted was between 5 and 50 nmoles. Not more than 10% of the alanine was converted to product. . In each procedure, the total extraction volume was 3 ml. The "nucleotide-tripeptide assay" was used to establish the amount of UDP-NAc-muramyl-Lala-D-glu-L-lys, and the N-acylamino sugar was determined by the method of Reissig et al. (18) .
version of the nucleotide-tripeptide to the nucleotidepentapeptide according to the following reaction:
The D-ala-D-ala adding enzyme from S. aureus Copenhagen is specific for UDP-NAc-muramyl-tripeptide tion at 23,000 X g, and the supernatant fraction was assayed for UDP-NAc-muramyl-tripeptide and N-acylamino sugar. A number of different extraction procedures were considered ( Table 1 ). The one described above is similar to that used by Strominger (25) . In Table 1 , four samples of late-log phase S. faecalis R (ATCC 8043) were subjected to the following procedures for extraction: (i) standard extraction procedure; (ii) four cycles of freezing and thawing (fraction A), followed by extraction with water at 100 C (fraction B); (iii) extraction with 7% perchloric acid at 0 to 4 C according to the procedure of Saukkonen and Virkola (20) ; (iv) extraction with 10% trichloroacetic acid according to the method described by Strominger (24) . From the data in Table 1 , it was apparent that each method allowed for the effective extraction of the UDP-NAc-muramyl-tripeptide. There was a lower yield of N-acylamino sugar in those procedures which utilized acid.
The "nucleotide-tripeptide assay" was evaluated with regard to the following. standard was used to correct the amount of UDPNAc-muramyl-tripeptide that was present in the extract. The largest correction was 17%, with the average around 5%. Analytical procedures. N-acylamino sugar was determined by the semimicro method of Reissig et al. (18) . When the water extracts were used, the samples were hydrolyzed in 0.13 M HCI by placing the tube in a boiling-water bath for 3 min. The reaction mixtures were neutralized before assaying. The standard muramic acid was acetylated with acetic anhydride according to the procedure described by Strominger et al. (27) . The e585 for N-acetyl-muramic acid and UDP-NAc-muramyl-tripeptide was 23, 200 . Measurements of radioactivity were made in polyethylene vials with a Packard Tri-Carb scintillation spectrometer (model 314-EX). The scintillation fluid was prepared according to Bray (2) . All measurements were made for 105 counts.
Chromatography. The nucleotides were chromatographed on Whatman 3MM paper in the following descending solvent system: (A) isobutyric acid- 2C. D-a-Amino-n-butyric acid and D-serine partially reversed the effects of O-carbamyl-Dserine. The same concentration of D-norvaline had no effect. Accumulation of UDP-NAc-muramyl-L-ala-Dglu-L-lys as a function ofgrowth phase. A control culture was examined for the accumulation of UDP-NAc-muramyl-tripeptide (Fig. 3A) . The amount of this nucleotide per milligram (dry weight) remained constant until the stationary phase of growth was attained. An increase in nucleotide was then observed. Thus, after 2 hr in the stationary phase, UDP-NAc-muramyl-tripeptide constituted over 50% of the total Nacylamino sugar (Fig. 3B) . In the medium, the amount of UDP-NAc-muramyl-tripeptide was undetectable until after the stationary phase was attained (Fig. 3C) . 
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* D-Ala-D-ala synthetase was measured by the "assay for ADP formation" described by Neuhaus (12) . The (Fig. 3D) . UDP-NAc-muramyl-tripeptide accumulated during the exponential phase of growth. The fraction of this nucleotide in the cytoplasm reached 0.6 at 150 min (Fig. 3B) .
At 120 min, the cells grown in the presence of O-carbamyl-D-serine contained 15 .6 nmoles of UDP-NAc-muramyl-tripeptide per mg (dry weight) of cells, and the control culture contained 0.55 nmoles/mg (dry weight). In contrast to the control culture, there was a rapid accumulation of UDP-NAc-muramyl-tripeptide in the medium (Fig. 3C) .
Effect of O-carbamyl-D-serine on the enzymes responsible for the incorporation ofalanine into the complete nucleotide UDP-NAc-muramyl-L-ala-D-glu-L-lys-D-ala-D-ala. Alanine racemase. The rates of alanine racemization were measured at varying concentrations of alanine at three concentrations of O-carbamyl-D-serine (Fig. 4A and   B ). In Fig. 4A the "L-alanine to D-alanine assay" was used, and in Fig. 4B the "D-alanine to L-alanine assay" was used. In both assays, 0-carbamyl-D-serine was a competitive inhibitor of the racemization. Table 3 .
D-Ala-D-ala-synthetase. With the synthetase, two effects have been examined. The first involved the synthesis of the mixed dipeptide D-ala-Ocarbamyl-D-ser, and the second involved the inhibition by this dipeptide of the synthesis of D-ala-D-ala. Previous studies (12, 13) The enzyme preparation was added to the assay mixture at 37 C and incubated for 5 min at this temperature. The reaction was terminated by the addition of 0.5 ml of 0.2 N sodium citrate buffer, pH 2.2. The UDP-NAc-muramylpentapeptide was separated and assayed for radioactivity as previously described (14) . The Previous studies with the synthetase (12, Neuhaus et al., unpublished data) have demonstrated that the product of the synthetase was an effective inhibitor of the reaction. The results (Table 4) 
DIscussIoN
The incorporation of D-alanine from L-alanine into peptidoglycan is summarized in Fig. 11 . Four potential sites of action of O-carbamyl-Dserine have been considered: alanine racemase, D-ala-D-ala synthetase, D-ala-D-ala adding enzyme, and phospho-NAc-muramyl-pentapeptide translocase. Two approaches have been used to establish the site of action of O-carbamyl-Dserine. The first has been to determine the effects on intact cells, and the second, to study the effects of the antibiotic on the enzymes described above. The correlation of these approaches may provide a definition of the mechanism by which O-carbamyl-D-serine affects the bacterial cell.
The studies with S. faecalis R confirmed the observations made by Tanaka et al. (30) that growth in the presence of the antibiotic resulted in lysis and that its action was reversed by D-alanine. Skinner et al. (21) reported that the D-isomer had no effect on S. lactis, Lactobacillus arabinosus, and Escherichia coli at 200 Ag/ml (1.3 X 10-M). Since 5 X 10-3M was required for growth inhibition, these results were also in agreement with those reported by Skinner et al. (21) . In addition, the medium used by Skinner et al. (21) contained a significant concentration of D-alanine (2.3 X 10-4 M), which would reverse the effect of O-carbamyl-D-serine. These results also confirmed that growth in the presence of the antibiotic caused the accumulation of N-acylamino sugar (30) . In this paper, it was demonstrated that the accumulation of N-acylamino sugar was the result of UDP-NAc-muramyl-Lala-D-glu-L-lys. It is recognized that other nucleotides may have accumulated in small amounts which were not quantified by the "nucleotide-tripeptide assay."
There are two distinct cell-wall phenomena which could result in lysis or inhibition of growth. One is the inhibition of cell-wall biosynthesis, and the other is the synthesis of defective wall material. If the bacterium is deprived of the cellwall precursor UDP-NAc-muramyl-L-ala-D-glu-L-lys-D-ala-D-ala, lysis or inhibition of growth results because of inadequate wall synthesis. Toennies et al. (33) suggested that lysis occurs as a consequence of the imbalance between degradative and synthetic processes involved in wall formation. On the other hand, defective wall structure as a consequence of analogue incorporation may result in growth inhibition or lysis, or both. The defective structure may not withstand the osmotic pressure differential, or it may not be able to serve as a primer for further synthesis of wall material. Lark and Lark (9) and Lark et al. (8) reported that the growth of Alcaligenes faecalis in the presence of D-methionine induced the formation of spheroplasts, and that Cl"-methionine was incorporated into the wall. 
